U.S. Markets open in 6 hrs 26 mins

Morgan Stanley: Salesforce Shares Aren't Pricing In Strong Free Cash Flow Growth

Dave Royse

Salesforce.com, inc. (NYSE: CRM) is being overlooked by investors despite strong revenue and free cash flow growth potential, according to Morgan Stanley. 

The Analyst

Keith Weiss maintained an Overweight rating on Salesforce with a $178 price target.

The Thesis

A strong case for 25%-plus free cash flow growth isn’t priced into Salesfore shares and that, coupled with investor concern around a slowdown in the core business, creates a “strong buying opportunity” in a core service-as-a-software asset, Weiss said in a Friday note. (See his track record here.) 

The analyst said he sees a clear path for Salesforce to more than double revenues by fiscal 2023, even with merger and acquisition dilution in the near-term.

Salesforce shares have underperformed, advancing just 3% year-to-date against its software peer group thanks to M&A dilution, Weiss said.

The company earlier this summer sealed up a .7-billion acquisition of data analytics firm Tableau Software. 

Salesforce enjoys a favorable competitive position, and there’s healthy customer demand across its product offerings, the analyst said. 

"With enterprise IT spend focused on digital transformation, Salesforce remains one of the best secularly positioned names in software and a long-term share gainer within an estimated $200B+ Total Addressable Market." 

Price Action

Salesforce shares were down 1.84% at $140.73 at the close Monday. 

Related Links:

KeyBanc: Salesforce Poised To Benefit From Data Opportunity After Tableau Acquisition

Tableau CEO On Synergies With Salesforce: The 'Best Of Both Worlds'

Photo courtesy of Salesforce. 

Latest Ratings for CRM

Date Firm Action From To
Aug 2019 Initiates Coverage On Buy
Jun 2019 Maintains Buy
Mar 2019 Initiates Coverage On Outperform

View More Analyst Ratings for CRM
View the Latest Analyst Ratings

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.